The Latest

Pressure Mounts on Truvada PrEP Pricing With Lawsuit and Congressional Hearings

"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."

By Tim Murphy

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

By Tim Murphy

HIV Activist Jumps Into the Philadelphia City Council Race

Housing and displacement are a major focus of their campaign.

By Kenyon Farrow

New York City Faces Challenge to HIV/AIDS Progress With Proposed $59 Million in Cuts From Governor Cuomo

Five years after Andrew Cuomo announced his plan to end New York state's HIV epidemic by 2020, the governor is shutting off funds to vital HIV prevention and public health programs in New York City.

By Tim Murphy

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

By Tim Murphy

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

By Charles Sanchez

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

By Sony Salzman

Trump's Justice Department Just Declared All-Out War on Obamacare. What Does It Mean?

We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.

By Tim Murphy

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

By Sony Salzman

What You Should Know About the House of Representatives' New "Medicare for All" Bill

Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.

By Tim Murphy